Treatment of severe ocular hypotony in AIDS patients with cytomegalovirus retinitis and cidofovir-associated uveitis.
Soltau
J B
JB
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000818:Animals; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000077404:Cidofovir; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy*; D003596:Cytosine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003846:Deoxyepinephrine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D015814:Ocular Hypotension / Q000139:chemically induced / Q000188:drug therapy*; D009883:Ophthalmic Solutions; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D014606:Uveitis, Anterior / Q000139:chemically induced*
D000998:Antiviral Agents; D018491:Dopamine Agonists; D005938:Glucocorticoids; D009883:Ophthalmic Solutions; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003907:Dexamethasone; D003596:Cytosine; C023487:ibopamine; D000077404:Cidofovir; D003846:Deoxyepinephrine